Skip to search formSkip to main contentSkip to account menu

Atovaquone 250 MG / proguanil hydrochloride 100 MG Oral Tablet

Known as: ATOVAQUONE 250 mg / PROGUANIL HYDROCHLORIDE 100 mg ORAL TABLET, FILM COATED [Atovaquone and Proguanil HCl], atovaquone 250 MG / proguanil HCl 100 MG Oral Tablet, ATOVAQUONE 250MG/PROGUANIL HCL 100MG TAB [VA Product] 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2018
2018
Malaria is a potentially life-threatening disease caused by infection with the Plasmodium protozoa transmitted by an infective… 
2016
2016
BACKGROUND Current guidelines recommend daily dosing of atovaquone-proguanil (AP), beginning a day before travel to endemic areas… 
2014
2014
BackgroundArtemisinin resistance is a major threat to current efforts to eliminate Plasmodium falciparum malaria which rely… 
2012
2012
Background The predominance of chloroquine-susceptible falciparum malaria in Malawi more than a decade after chloroquine's… 
Review
2008
Review
2008
We discuss a case of atovaquone-proguanil treatment failure in a child from Mozambique, recently arrived in North America. Four… 
2006
2006
Objective: To describe the clinical features and management of African migrants recently arrived in Western Australia and… 
2001
2001
ZusammenfassungBei der individuellen Beratung über die Notwendigkeit einer Malariaprophylaxe muss man zwischen dem Risiko an… 
2000
2000
ABSTRACT The naphthoquinone atovaquone is effective againstPlasmodium and Pneumocystis carinii carinii. InPlasmodium, the primary…